Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × ALT-803 × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Lymphoma, B-Cell 2 Colorectal Neoplasms 2 Carcinoma, Transitional Cell 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Neoplasm, Residual 1 Microsatellite Instability 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Gemcitabine 26 pembrolizumab 19 Cisplatin 19 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 durvalumab 10 Nivolumab 9 enfortumab vedotin 8 avelumab 8 atezolizumab 7 Carboplatin 7 Mitomycin 6 Docetaxel 6 Cystoscopy 6 Cystectomy 6 Radiation 5 Paclitaxel 5 Biopsy 5 sacituzumab govitecan 4 Transurethral Resection of Bladder 4 Standard of Care 4 Radiotherapy 4 Ipilimumab 4 Fluorouracil 4 erdafitinib 3 dehydroftorafur 3 cabozantinib 3 Practice Guidelines as Topic 3 Platinum 3 Mitozytrex 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡